Introduction
Chromosomal rearrangements leading to fusion of protein oligomerization domains to tyrosine kinase domains occur in a number of malignancies (Rabbitts, 1994; Sawyers and Denny, 1994) . The t(5;12) translocation, associated with chronic myelomonocytic leukemia (CMML), generates a fusion gene encoding a protein composed of the 154 amino-terminal amino acids of TEL and the transmembrane and intracellular tyrosine kinase domain of the PDGF b-receptor (PDGFbR) (Golub et al., 1994) .
The PDGFbR is composed of an extracellular part, consisting of ®ve Ig-like domains, a transmembrane segment and an intracellular part containing a split tyrosine kinase domain. PDGF-BB, the ligand of the PDGFbR, induces activation of PDGFbR through dimerization of receptors. Dimerization of receptors leads to activation of the intrinsic kinase activity and subsequent autophosphorylation of tyrosine residues in the intracellular part, which serve as docking sites for SH-2-domain-containing signaling proteins (Heldin et al., 1998) . Dysregulated activation of the PDGFbR, through ectopic ligand production, has been suggested to contribute to malignant cell growth in a number of dierent tumor types, including glioblastomas, mesotheliomas and sarcomas (reviewed in Heldin and Westermark, 1996) . Also, in addition to the TELPDGFbR fusion protein, two other genetic rearrangements giving rise to fusion proteins containing the kinase domain of the PDGFbR has recently been identi®ed; the CEV14-PDGFbR and HIP-PDGFbR genes isolated from an AML and a CMML patient, respectively (Abe et al., 1997; Ross et al., 1998) .
TEL, also known as ETV6, is a 452 amino acid residue protein of the ETS family of sequence speci®c transcription factors (Ghysdael and . The ETS family members contain a conserved DNA binding domain, the ETS domain. A subset of ETS proteins, including TEL, also contains a conserved amino-terminal domain termed the pointed domain/B domain. This domain has been shown to be necessary and sucient for homophilic self-association of TELPDGFbR (Carroll et al., 1996; Jousset et al., 1997) . Malignancy-associated chromosomal rearrangements leading to fusion of the pointed/B domain of TEL to a number of other tyrosine kinases, including c-ABL, JAK2 and TRK-C, have recently been characterized (Golub et al., 1995; Knezevich et al., 1998; Lacronique et al., 1997; Papadopoulos et al., 1995) . In vitro and in vivo transforming ability of TEL-PDGFbR and TEL-JAK2 has been demonstrated (Carroll et al., 1996; Jousset et al., 1997; Schwaller et al., 1998; Thomasson et al., 1999) . TEL has also been described as a fusion partner in human leukemias for other transcriptional regulators like AML1 and CDX2 (Chase et al., 1999; Golub et al., 1995; Romana et al., 1995) .
The aim of the present study was to further investigate the importance of TEL-mediated oligomerization for the activation of TEL-PDGFbR and to compare the signaling properties of TEL-PDGFbR and ligand-activated PDGFbR. We show that overexpression of the TEL moiety leads to reduction of tyrosine phosphorylation of the fusion protein. We also demonstrate dierences in the signaling capacity between ligand-stimulated PDGFbR and TELPDGFbR and provide evidence for the presence of unique autophosphorylation sites in TEL-PDGFbR.
Results
TEL-PDGFbR-stimulated IL-3-independent growth of BaF/3 cells is blocked by the PDGF receptor kinase inhibitor AG1296 TEL-PDGFb is a constitutively active tyrosine kinase able to relieve the IL-3 requirement of BaF/3 cell survival and proliferation (Carroll et al., 1996; Jousset et al., 1997) . To evaluate the role of the tyrosine kinase activity of TEL-PDGFbR in its ability to stimulate IL-3 independent growth of BaF/3 cells, the eects of the selective PDGF receptor inhibitor AG1296, which blocks ATP binding of the receptor, was investigated (Kovalenko et al., 1994) .
As shown in Figure 1a , culturing in the presence of the inhibitor reduced, in a dose-dependent manner, the growth of TEL-PDGFbR-BaF/3 cells. The eect of AG1296 on the growth of TEL-PDGFbR-BaF/3 was concluded to be mediated through targeting of the tyrosine kinase activity of TEL-PDGFbR since no eect was observed either on BaF/3 cells stably expressing the v-mpl oncoprotein or on TELPDGFbR-BaF/3 cells cultured in the presence of IL-3 ( Figure 1a ). The inhibitory eect of AG1296 on TELPDGFbR tyrosine kinase activity was directly demonstrated by analysing the immunoprecipitated fusion protein with respect to tyrosine phosphorylation ( Figure 1b) . As shown, inhibition of tyrosine phosphorylation of TEL-PDGFbR occurred in the same concentration range as was required to suppress the growth of TEL-PDGFbR-BaF/3 cells.
We thus conclude, in agreement with previous studies (Carroll et al., 1996 (Carroll et al., , 1997 Jousset et al., 1997) , that the tyrosine kinase activity of TELPDGFbR is required for its ability to stimulate IL-3-independent growth of BaF/3 cells.
TEL-PDGFbR occurs as cross-linkable multimers in vivo
The pointed/B domain of TEL has been shown to be sucient to mediate homophilic protein ± protein interactions (Jousset et al., 1997) . To investigate if TEL-PDGFbR occurred as dimers and/or multimers in vivo, the fusion protein was transiently expressed in COS cells and analysed by immunoprecipitation and immunoblotting after the addition to the cell lysate of a covalent cross-linker, bis(sulfosuccinimidyl)suberate. Unstimulated and ligand-stimulated wild-type PDGFbR were analysed in parallel. As shown in Figure 2 , dimeric forms of the wild-type PDGFbR was detected in a ligand-dependent manner (Figure 2 , lanes 3 ± 6). In the case of TELPDGFbR, which as a monomer migrates as a component with an M r of approximately 90 000 in SDS gel-electrophoresis, addition of cross-linker to cell lysates generated multiple component(s) with M r s of 250 000 ± 500 000. No distinct component of the expected size of a dimer was detected (Figure 2 , lanes 7 and 8).
These results thus con®rm the ability of the TELmoiety of TEL-PDGFbR to mediate homophilic interactions. However, in contrast to the ligandstimulated wild-type PDGFbR which occurs as a dimer, TEL-PDGFbR appears to exist predominantly as oligomeric or multimeric complexes. The observation that TEL-PDGFbR eluted very close to the V o fraction, when analysed by size-exclusion chromatography, lends further support to this conclusion (data not shown).
Overexpression of the TEL-moiety reduces the tyrosine phosphorylation of TEL-PDGFbR
The mechanism underlying the constitutive tyrosine phosphorylation of TEL-PDGFbR has been suggested to involve pointed/B domain-mediated oligomerization of TEL-PDGFbR (Carroll et al., 1996; Jousset et al., 1997) . To experimentally test this hypothesis we investigated the eects of co-expression of a truncated form of TEL-PDGFbR, lacking the kinase domain (HA TP-0tt) (Jousset et al., 1997) , on TEL-PDGFbR tyrosine phosphorylation. TEL-PDGFbR and v-mpl expressing BaF/3 cells were preincubated with the indicated concentrations of AG1296 for 2 h before harvesting. Cell lysates were subjected to immunoprecipitation (IP) with PDGF breceptor antibody followed by SDS-gel electrophoresis in 7% gels. After transfer to PVDF membranes, samples were analysed by immunoblotting (IB) using phosphotyrosine antibody and HA epitope antibody COS cells were transiently transfected either with an HA-tagged form of TEL-PDGFbR alone, or together with an excess of HA TP-0tt. Expression of the two proteins was detected by immunoprecipitation with an antiserum against the HA-epitope followed by immunoblotting with an HA monoclonal antibody ( Figure 3 ). The expression levels of TEL-PDGFbR were similar in both transfections ( Figure 3 , middle panel). To determine the extent of tyrosine phosphorylation of TEL-PDGFbR, the ®lter was reprobed with phospho-tyrosine antibodies. As shown in the top panel, co-expression of HA TP-0tt signi®cantly reduced the tyrosine phosphorylation of TEL-PDGFbR. By comparing the phospho-tyrosine signal from dierent amounts of immunoprecipitated TEL-PDGFbR the speci®c tyrosine phosphorylation of TEL-PDGFbR was estimated to be reduced more than 50% after coexpression of HA TP-0tt (data not shown).
We thus conclude that TEL-mediated homophilic interactions contribute to the constitutive tyrosine phosphorylation of TEL-PDGFbR and constitute a candidate target for antagonists.
Ligand-stimulated PDGFbR and TEL-PDGFbR dier in signaling properties
To compare the signaling properties of ligandstimulated wild-type PDGFbR and TEL-PDGFbR, BaF/3 cells were electroporated with a PDGFbR expression vector conferring G418 resistance. After selection with G418 in the presence of IL-3, a population of resistant BaF/3 cells were obtained and analysed with regard to PDGFbR expression. Cell lysates from unstimulated and PDGF-stimulated cells were subjected to immunoprecipitation with a PDGFbR antiserum and subsequently analysed by PDGFbR and phospho-tyrosine immunoblotting. As shown in Figure 4 , both precursor and mature forms of the PDGFbR, with the expected sizes of 160 and 180 kDa, respectively, were detected. The PDGFbR was functionally active as evidenced by tyrosine phosphorylation in response to PDGF-BB ( Figure  4a ). Comparison with TEL-PDGFbR expressing BaF/ 3 cells revealed similar expression levels of the two proteins ( Figure 4b ).
The PDGFbR expressing BaF/3 was used to investigate if ligand-stimulated PDGFbR was able to confer IL-3-independent growth of BaF/3 cells. Cells expressing wild-type PDGFbR, cells transfected with an empty expression vector and TEL-PDGFbR expressing cells were deprived of IL-3, and seeded in 96-well plates in the absence or presence of IL-3 or PDGF-BB. As shown in Table 1 , this analysis revealed that ligand-stimulated PDGFbR, in contrast to TELPDGFbR, was unable to stimulate IL-3 independent proliferation of BaF/3 cells.
These ®ndings thus suggest that TEL-PDGFbR signaling diers qualitatively from that of ligand stimulated wild-type PDGFbR.
Identi®cation of unique tyrosine phosphorylation sites in TEL-PDGFbR
To explore the possibility that the dierences in signaling between wild-type PDGFbR and TELPDGFbR occurred as a consequence of unique tyrosine phosphorylation sites in TEL-PDGFbR, the tyrosine phosphorylation patterns of the two proteins were compared.
TEL-PDGFbR and ligand-stimulated wild-type PDGFbR were immunoprecipitated from transiently transfected COS cells and autophosphorylation sites were labeled with radioactive phosphate through an in vitro kinase assay. Tryptic peptides derived from the labeled TEL-PDGFbR and PDGFbR were isolated and separated by two dimensional analysis by high voltage electrophoresis followed by thin layer chroma- Figure 2 Evidence for oligomeric complexes of TEL-PDGFbR by crosslinking. Analysis was performed using COS cells transfected with TEL-PDGFbR (lanes 7 and 8) or wild-type PDGF b-receptor in the absence (lanes 3 and 7) or presence (lanes 5 and 6) of PDGF-BB stimulation. After lysis, samples were treated without (7) or with (+) the crosslinker bis(sulfosuccinimidyl) suberate, and the lysates were immunoprecipitated with PDGF b-receptor antibody. Following SDS-gel electrophoresis in 7% gels and transfer to PVDF membranes, PDGF b-receptor and TEL-PDGFbR were detected by PDGF breceptor immunoblotting Figure 3 Phosphorylation of the TEL-PDGFbR protein is reduced by cotransfection with excess HA TP-0tt construct. COS cells were mock transfected, transfected with cDNA encoding HA-epitope tagged TEL-PDGFbR alone and/or a tenfold excess of HA TP-0tt. Cell lysates were subjected to immunoprecipitation (IP) with HA epitope antibody followed by SDS-gel electrophoresis in 7% gels and 15% gels. After transfer to PVDF membranes, samples were analysed by immunoblotting (IB) using a phosphotyrosine antibody (upper panel, 7% gel) and HA epitope antibody (middle panel, 7% gel; lower panel, 15% gel) tography (Figure 5a,b) . Comparison of the two patterns revealed the presence of two unique 32 Plabeled TEL-PDGFbR derived peptides, TP-1 and TP-2 (Figure 5b) .
Phosphoamino-acid analysis was performed of TP-1 and TP-2 and demonstrated exclusively phosphorylation of tyrosine residues ( Figure 5c ). As shown in Figure 5c , both peptides contained radioactively labeled residues at positions 3 and 13. Inspection of the amino-acid sequence of TEL-PDGFbR revealed that the only sequence containing tyrosine residues 3 and 13 amino-acid residues downstream of a tryptic cleavage site occurred carboxy-terminal of the arginine residue at position 14. This analysis therefore demonstrates that tyrosine residues at positions 17 and 27 of the TEL-PDGFbR serve as autophosphorylation sites in vitro.
To investigate if these sites were also phosphorylated in vivo, TEL-PDGFbR and ligand-stimulated PDGFbR were 32 P-labeled by incubation of transfected COS cells with [ 32 P]orthophosphate. After immunoprecipitation, tryptic peptides were generated and analysed by two dimensional analysis (Figure 5d,e) . From TEL-PDGFbR, but not from PDGFbR, two peptides migrating similar to TP-1 and TP-2 were recovered (Figure 5e ).
Based on the identi®cation of tyrosine residues 17 and 27 as in vitro autophosphorylation sites and on the migratory pattern of the TP-1 and TP-2 peptides derived from in vivo labelings, we suggest that tyrosine residues 17 and 27 serve as unique TEL-PDGFbR in vivo autophosphorylation sites.
Alteration of tyrosine residues 17 and 27 to phenylalanine residues does not aect TEL-PDGFbR ability to stimulate IL-3 independent growth or colony formation
To investigate if tyrosine residues 17 and 27 were required for the capacity of TEL-PDGFbR to promote IL-3 independent proliferation, BaF/3 cells expressing a mutant form of TEL-PDGFbR, in which tyrosine residues 17 and 27 were altered to phenylalanine Wild-type PDGFbR BaF/3 cells or control BaF/3 cells were deprived of IL-3 and seeded in 96-well trays at a concentration of 10 4 cells per well in the absence or presence of 20 ng/ml PDGF-BB or in the presence of 2% WEHI-CM as a source of IL-3. The number of wells showing proliferating cells was scored after 20 days in culture. *Expression of PDGFbR in BaF/3 cells in the presence of PDGF-BB permitted cell survival in 10% of the wells but failed to induce sustained proliferation of these cells Control cells and cells expressing TEL-PDGFbR or TEL-PDGFbR Y17,27F were deprived of IL-3 and seeded in 96-well trays at a concentration of 10 4 cells per well. The number of wells showing proliferating cells in either the absence or presence of IL-3 was scored after 12 days in culture. TEL-PDGFbR or TEL-PDGFbR Y17,27F expressing BaF/3 cells were generated following transfection with the appropriate pBabe Puro expression vector and puromycin selection. Cells deprived of IL-3 were seeded in 1% methyl cellulose and the number of colonies was scored after 12 days in culture (mean colony counts of duplicate+s.e.m.) residues (TEL-PDGFbR-Y17,27F) were established. Expression levels of TEL-PDGFbR-Y17,27F was demonstrated by PDGFbR immunoprecipitation, followed by PDGFbR immunoblotting and shown to be similar to that of TEL-PDGFbR ( Figure 6 , upper panel). Comparison of the tyrosine phosphorylation of TEL-PDGFbR-Y17,27F and TEL-PDGFbR did not reveal any major dierences in the extent of tyrosine phosphorylation ( Figure 6, lower panel) .
BaF/3 cells expressing TEL-PDGFbR-Y17,27F were analysed with regard to IL-3 independent growth as well as formation of colonies in methylcellulose. As shown in Table 2 , substitution of tyrosine residues 17 and 27 with phenylalanine residues did not aect the functional properties of TEL-PDGFbR as determined by these assays.
Thus, phosphorylation of tyrosine residues 17 and 27 of TEL-PDGFbR is not required for the ability to confer IL-3-independent proliferation of BaF/3 cells.
Discussion
The ®ndings in the present study extends previous characterization of the chronic myelomonocytic leukemia-associated TEL-PDGFbR fusion protein. Interference with pointed/B domain-mediated homophilic interactions were demonstrated to reduce tyrosine phosphorylation of TEL-PDGFbR (Figure 3) . When ligand-stimulated wild-type PDGFbR and TELPDGFbR were compared with regard to ability to confer IL-3-independent proliferation, dierences in signaling potency of the two proteins were revealed ( Figure 4 , Table 1 ). Finally, two autophosphorylation sites were identi®ed in the TEL moiety of the fusion protein ( Figure 5 ).
Since the original identi®cation of TEL as a fusion partner for PDGFbR, three additional fusion proteins containing the amino-terminal part of TEL fused to tyrosine kinases have been identi®ed; TEL-ABL, TEL-JAK2 and TEL-TRKC (Golub et al., 1995; Knezevich et al., 1998; Lacronique et al., 1997; Papadopoulos et al., 1995) . In the cases of TEL-PDGFbR, TEL-ABL and TEL-JAK2, biochemicial evidence for TEL-moiety P-ortophosphate-containing medium. Ligandstimulated PDGFbR and TEL-PDGFbR were immunoprecipitated using PDGF b-receptor antiserum, separated by SDS ± PAGE and electrotransferred to a nitrocellulose membrane. Bands corresponding to the phosphorylated PDGF b-receptor and TEL-PDGFbR protein were cut out and subjected to tryptic cleavage. Phosphopeptides were analysed as in (a) and (b) mediated activation of associated tyrosine kinase activity has been demonstrated (Carroll et al., 1996; Golub et al., 1996; Jousset et al., 1997; Lacronique et al., 1997; Papadopoulos et al., 1995) . Our ®nding that overexpression of the TEL-moiety reduces the tyrosine phosphorylation of TEL-PDGFbR provides experimental evidence for an antagonistic strategy that has previously only been suggested. Although it remains to be experimentally proven, it is likely that a similar strategy could be used to interfere with signaling of TEL-ABL, TEL-JAK2 and TEL-TRKC. Our ®ndings thus suggest that the pointed/B domain homophilic interaction is a candidate target for drug development. In this context, the recently reported structures of the pointed/B domain of Ets-1, and of the structurally related SAM domains of the Eph4A and EphB2 receptor tyrosine kinases, are of great interest (Slupsky et al., 1998 , Stapleton et al., 1999 Thanos et al., 1999) .
BaF/3 cells have previously been used as a model system to study PDGFbR signaling. IL-3 independent proliferation was observed after co-expression of PDGFbR and v-sis, the viral homologue of PDGF Bchain (Drummond-Barbosa et al., 1995) . In contrast we observed that ligand-stimulated PDGFbR expressing BaF/3 cells fail to proliferate in absence of IL-3. One possible explanation to the dierence between our ®ndings and the ®ndings in the study of DrummondBarbosa et al. (1995) are variations in PDGFbR expression levels. Alternatively, the dierences occur as a consequence of dierences in signaling triggered by receptors stimulated in an autocrine fashion and by receptors stimulated by exogenously added ligands. The notion that signals leading to IL-3 independent proliferation can be transmitted from activated intracellular receptors, are supported by the occurrence of IL-3 independent proliferation of 32D cells co-expressing vsis and PDGF a-and b-receptor chimeras which did not reach the cell surface (Staebler et al., 1995) .
In the case of the comparison between TEL-PDGFbR and ligand-stimulated PDGFbR, presented in this study, similar expression levels of the two proteins were demonstrated. However, continuous ligand stimulation will most likely lead to ligand-induced downregulation of the PDGFbR, and eventually reduced steady-state signaling as compared to the TEL-PDGFbR ligandindependent signaling. The dierences in subcellular localization of TEL-PDGFbR and wild-type PDGFbR might provide access to dierent substrates for the two forms and therefore underlie the phenotypic dierence, as discussed above. Finally, the unique autophosphorylation sites in the TEL-PDGFbR could lead to recruitment of a dierent set of SH2-domain-containing signaling proteins. It is noteworthy, that in the wellstudied BCR-ABL fusion protein, phosphorylation in the BCR-part creates a GRB2-binding site of importance for the transforming property of the fusion protein (Goga et al., 1995; Pendergast et al., 1993) . The observation that the Y17,27F mutant retained the ability to confer IL-3 independent proliferation rules out a role of these tyrosine residues as necessary for this particular phenotype. However, before excluding a functional role of these sites, the mutant and wild-type should be compared in additional models of hematopoetic malignancies, like retrovirally mediated transfer into primary bone marrow cells or in transgenic mice. Whether the same sites are phosphorylated in other TEL-tyrosine kinase fusion proteins also merits further investigation.
Materials and methods

Generation of expression vectors and stable BaF/3 cell lines
cDNA encoding human wild-type PDGFbR (Claesson-Welsh et al., 1988) was subcloned into the pcDNA3 neo vector. This construct and pcDNA3 neo control (control) were introduced by electroporation into the murine IL-3-dependent BaF/3 cells, as described previously (Jousset et al., 1997) .
To convert tyrosine 17 and 27 of TEL-PDGFbR into phenylalanine, M13-TEL-PDGFbR recombinant DNA (Jousset et al., 1997) was subjected to oligonucleotide sitedirected mutagenesis. The sequence of the mutagenic primer used was 5'-CGAGGAAGCGAAACTCGGGGCACTGGG-CTCTCTGGAGGTGTAAATGAAATTCGTTCC-3'. An EcoRI/SstII fragment originating from the site directed mutagenized insert was sequenced and subcloned into EcoRI and SstII restricted pBS-TP-0 (Jousset et al., 1997) . The complete TEL-PDGFbR Y17,27F insert was subcloned into EcoRI and SalI restricted pBabe puro retroviral expression vector (Morgenstern and Land, 1990) . The TEL-PDGFbR Y17,27F insert of this construct (pBabe puro TP Y17,27F) was checked by sequencing.
pBabe puro vectors encoding TEL-PDGFbR Y17,27F as well as wild-type TEL-PDGFbR were introduced by electroporation into the murine IL-3-dependent BaF/3 cells, as described previously (Jousset et al., 1997) , and stably transfected cells were selected in the presence of 1 mg/ml puromycin and 2% WEHI conditioned medium as source of IL-3. cDNA encoding human wild-type PDGFbR was subcloned into the pBabe neo retroviral expression vector. The v-mpl BaF/3 cell line was a kind gift of I Dusanter and S Gisselbrecht (ICGM, Paris) and the PBabe neo TELPDLFbR BaF/3 cell lines has been described earlier (Bousset et al., 1997) .
COS cell transfections
COS cells were maintained in DMEM medium supplemented with 10% fetal calf serum and antibiotics. Plasmids encoding wild-type PDGFbR, HA epitope tagged TEL-PDGFbR and/ or HA TP-0tt construct (Jousset et al., 1997) were transfected into semicon¯uent COS cells by the calcium phosphate method. In cotransfection experiments, TEL-PDGFbR plasmid was transfected alongside with a tenfold molar excess of HA TP-0tt construct. Cells were harvested for analysis 2 days after transfection.
Immunoprecipitation, immunoblotting and crosslinking procedures
Cells were starved overnight in culture media containing 0.1% FCS, washed once in ice-cold phosphate-buered saline (PBS) with 0.1% bovine serum albumin (BSA) and stimulated with 100 ng/ml PDGF-BB for 1 h at 48C followed by rinsing in ice-cold PBS. After extraction with lysis buer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% Triton X-100, 0.5% deoxycholic acid, 10 mM EDTA, 1 mM phenylmethylsulfonyl¯uoride, 1% aprotinin, 200 mM Na 3 VO 4 ) and centrifugation at 10 000 g for 15 min, cell lysates incubated with rabbit antisera raised against the Cterminal part of the PDGFbR (Claesson-Welsh et al., 1988) or the HA epitope for 60 min at 48C. Following incubation with Protein A Sepharose 6MB (Amersham Pharmacia Biotech) for 30 min at 48C, samples were washed three times in lysis buer, heated for 5 min at 958C and subjected to SDS-gel electrophoresis. After semi-dry transfer onto polyvinylidene di¯uoride (PVDF) membranes and blocking in TBS/0.1% Tween-20, immunoblotting was performed using the PDGFbR antibodies P-20 (Santa Cruz Biotechnology) and 06-498 (UBI), phosphotyrosine antibodies PY20 (Transduction Laboratories) and 4G10 (Upstate Biotechnology, Inc.) and HA-epitope antibody (Boehringer Mannheim) in dilutions as recommended by the supplier.
For crosslinking studies, COS cells were transfected with plasmids encoding wild-type PDGFbR or TEL-PDGFbR, as described above. Cells were starved overnight in DMEM/ 0.1% FCS, rinsed once in PBS containing 0.1 mg/ml bovine serum albumin and stimulated with 100 ng/ml PDGF-BB for 60 min at 48C. After lysis in 20 mM HEPES pH 7.5, 1% Triton X-100, 5 mM EDTA, 0.15 M NaCl, 1 mM phenylmethylsulfonyl¯uoride (PMSF) and 1% aprotinin, samples were treated with 0.1 M bis(sulfosuccinimidyl) suberate for 1 h at 48C. Following incubation in 70 mM methylammonium chloride for 10 min, cell lysates were immunoprecipitated with antisera against the PDGF b-receptor, subjected to SDS-gel electrophoresis in 7% gels and immunoblotting using the anti-PDGFbR antibody P-20, as described above.
Identi®cation of phosphorylation sites in vitro and in vivo COS cells were transiently transfected with PDGF b-receptor or TEL-PDGFbR encoding plasmids. To inhibit the constitutive activity of TEL-PDGFbR, cells were incubated with 15 mM AG1296 for 24 h before experiments. Thirty minutes prior to lysis, cells were washed with medium to remove the inhibitor. In vitro kinase reactions were performed essentially as described (Hansen et al., 1996) . 32 P-orthophosphate labeling, trypsin digestion, two-dimensional phosphopeptide mapping and phosphoamino acid analysis was performed as earlier described (Blume-Jensen et al., 1995) .
Culture of BaF/3 cells
BaF/3 cells were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum and antibiotics. Wild-type PDGFbR expressing cells were cultured in the presence of 0.5 mg/ml G418 and 2% WEHI-conditioned media (CM) as a source of IL-3. AG1296 was added to culture media as a stock solution of 10 mM in DMSO to ®nal concentrations of 1.5, 5 or 15 mM alongside with vehicle control. TELPDGFbR and v-mpl expressing BaF/3 cells were seeded in duplicates at a concentration of 1610 5 cells/ml and subsequently grown for 72 h in the presence or absence of AG1296 followed by counting in a BuÈ rker chamber. Inhibition of TEL-PDGFbR tyrosine kinase activity by AG1296 was studied by a 2-h incubation of TEL-PDGFbR cells with the inhibitor.
To assess the degree of IL-3-independent growth, cells were deprived of IL-3 and seeded in 96-well trays at a concentration of 10 4 cells per well, as described previously (Lacronique et al., 1997) . In the case of PDGFbR expressing cells, culturing was performed in the absence or presence of 20 ng/ml PDGF-BB or in the presence of 2% WEHI-CM as a source of IL-3. The number of wells showing proliferating cells were scored after 12 ± 20 days in culture.
Colony formation was assessed by seeding TEL-PDGFbR and TEL-PDGFbR Y17,27F BaF/3 cells in 1% methylcellulose in RPMI supplemented with 10% FCS and antibiotics at a concentration of 5610 4 cells per ml. Scoring of colony numbers was done after 12 days in culture.
